Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kahn

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
FEBS Letters|November 19, 2003
Assessment of putative protein targets derived from the SARS genomeLisa Yan, Mikhail Velikanov, Paul Flook, et al.
BMJ Open|November 14, 2025
Clinical utility and cost-effectiveness of BeginNGS newborn screening by genome sequencing and standard newborn screening for severe childhood genetic diseases: an adaptive, international and comparative clinical trialRebecca Reimers, Miranda Bailey, Chester Brown, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
FEBS Letters|November 19, 2003
Assessment of putative protein targets derived from the SARS genomeLisa Yan, Mikhail Velikanov, Paul Flook, et al.
BMJ Open|November 14, 2025
Clinical utility and cost-effectiveness of BeginNGS newborn screening by genome sequencing and standard newborn screening for severe childhood genetic diseases: an adaptive, international and comparative clinical trialRebecca Reimers, Miranda Bailey, Chester Brown, et al.
Pageof 1